SUTRO BIOPHARMA, INC. Earnings Per Share Diluted

Quick Answer

SUTRO BIOPHARMA, INC. reported Earnings Per Share Diluted of $22.49 (loss) per share for the year ending 2025.

  • SUTRO BIOPHARMA, INC. showed an increase of +23.5% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from SUTRO BIOPHARMA, INC.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), SUTRO BIOPHARMA, INC.'s Earnings Per Share Diluted has declined by 2,171.7%.
  • Historical annual values: Fiscal year 2025: $22.49 (loss) per share | Fiscal year 2024: $29.40 (loss) per share | Fiscal year 2023: $1.78 (loss) per share | Fiscal year 2022: $2.35 (loss) per share | Fiscal year 2021: $2.29 (loss) per share | Fiscal year 2020: $0.99 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: